Related Experiment Videos
[Vasovagal syncope. Management with propanthelin bromide]
C Corbalá Fuentes1, A Pacheco Ureña, S Pedraza Ibarra
1Hospital General de Zona No. 3., IMSS, Mazatlán, Sinaloa.
Archivos Del Instituto De Cardiologia De Mexico
|May 1, 1997
Summary
Propanthelin bromide effectively prevents vasovagal syncope relapses in patients. This study found that the medication significantly reduced syncope episodes with minimal side effects, offering a promising treatment option.
Area of Science:
- Cardiology
- Neurology
Background:
- Vasovagal syncope is a common cause of syncope.
- Recurrent vasovagal syncope can significantly impact quality of life.
Purpose of the Study:
- To evaluate the efficacy of propanthelin bromide in preventing recurrent vasovagal syncope.
Main Methods:
- A prospective longitudinal study was conducted with 10 patients diagnosed with vasovagal syncope.
- Patients received 15-30 mg of propanthelin bromide thrice daily.
- A 12-month follow-up was performed to assess recurrence and side effects.
Main Results:
- Nine out of ten patients experienced no recurrence of vasovagal syncope.
- The majority of patients were women with a mean age of 18 years.
- Four patients reported minor side effects.
Conclusions:
- Propanthelin bromide is an effective treatment for reducing vasovagal syncope episodes.
- The medication demonstrates a favorable safety profile with few adverse effects.